Early Development & IND Enablement
Route scouting, synthetic process development, analytical method development, impurity profiling, and IND-enabling support to accelerate early-stage drug development.
Explore Custom API DevelopmentMeet us at CPHI Milan 2026, Booth No. 10H33, Oct 6-8, Fiera Milano, Italy Schedule a Meeting
From route scouting and process development to commercial API manufacturing, we help pharmaceutical and biotech companies accelerate development with scalable, regulatory-compliant CDMO solutions.
Explore Our CDMO Services
Phase-appropriate development and manufacturing support designed to reduce complexity, improve readiness, and accelerate progress from early development through commercial supply.
Route scouting, synthetic process development, analytical method development, impurity profiling, and IND-enabling support to accelerate early-stage drug development.
Explore Custom API DevelopmentNeuland’s small molecule CDMO services combine complex chemistry, scalable development, and commercial manufacturing to deliver reliable, regulator-ready API supply with reduced risk and long-term supply assurance.
Explore Small Molecule CDMO Services
Chemistry & reactions
Process development
Scale-up & tech transfer
Quality & compliance
Analytical R&D
Regulatory CMC
Commercial ManufacturingLeveraging SPPS, LPPS, and hybrid approaches, we deliver sequence-specific peptides with the quality, scalability, and consistency required for clinical and commercial success.
Explore Peptide CDMO Services
SPPS
LPPS
Hybrid
Quality & compliance
Analytical R&D
Regulatory CMC
Commercial manufacturingPartner with us for dependable API manufacturing backed by strong process expertise, global regulatory track record, and a focus on uninterrupted commercial supply.
Quality & complianceAnalytical R&DRegulatory CMCCommercial manufacturing
API product brochure
Built on process expertise, execution discipline and regulatory rigor.
Transparent, responsive engagement across every stage of your program.
Proven ability to solve challenging process and impurity problems.
Case studies and technical insights that demonstrate our expertise in solving complex challenges.
How Neuland used Design of Experiments to strengthen process understanding, optimize critical parameters, and support a more robust peptide API manufacturing process for Phase III requirements.
Read Technical Case StudyHave a complex molecule or development challenge? Connect with our experts to explore practical, scalable solutions from early development through commercial supply.
Quick answers to help you better understand our CDMO capabilities and approach.
Still Have Questions? Contact UsNeuland Labs is a trusted global CDMO, offering end-to-end support from molecule development to commercialization. With extensive expertise in complex chemistries, our team of scientists ensures seamless project execution for pharmaceutical and biotech companies.
Partnering with a CDMO for drug development and manufacturing offers benefits like access to specialized expertise and infrastructure, cost savings, faster time to market, and scalability, allowing pharma and biotech companies to focus on core competencies.
Neuland Labs supports the production of complex or niche drug development from milligrams to multi-kilogram scales by standard sequential chemical synthesis and segment condensation strategies. We enable the synthesis of linear and cyclic peptides with dedicated state-of-the-art equipment for custom peptide synthesis while adhering to green chemistry principles.
A CDMO can help optimize drug manufacturing process by leveraging their extensive expertise and resources, accelerating timelines, and ensuring regulatory compliance, from early formulation to commercial scale manufacturing.
Process optimization, impurity control, analytical alignment, and seamless technology transfer to support scale-up with confidence.
Explore Technology Transfer
cGMP manufacturing, quality systems, and supply continuity from clinical phase needs through commercial launch.
Explore Custom API Manufacturing
cGMP systems aligned to global regulatory expectations.
From development through commercial supply with continuity.
Trusted by 500+ pharma and biotech companies globally
Small Molecules | Peptides | Generic Drug Substances
Booth No. 805
Key considerations for successful drug development.
Trusted by 500+ pharma and biotech companies globally | We look forward to partnering with you.
